SEARCH

SEARCH BY CITATION

References

  • Alvarez C, Regan JP, Merianos D, Bass BL (2004). Protease-activated receptor-2 regulates bicarbonate secretion by pancreatic duct cells in vitro. Surgery 136: 669676.
  • Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y et al. (2007). Promoter hypomethylation of protease-activated receptor 2 associated with carcinogenesis in the stomach. J Gastroenterol Hepatol 22: 943948.
  • Asokananthan N, Graham PT, Fink J, Knight DA, Bakker AJ, McWilliam AS et al. (2002). Activation of protease-activated receptor (PAR)-1, PAR-2, and PAR-4 stimulates IL-6, IL-8, and prostaglandin E2 release from human respiratory epithelial cells. J Immunol 168: 35773585.
  • Barbara G, Wang B, Stanghellini V, de Giorgio R, Cremon C, Di Nardo G et al. (2007). Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 132: 2637.
  • Bohm SK, Kong W, Bromme D, Smeekens SP, Anderson DC, Connolly A et al. (1996). Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2. Biochem J 314 (Part 3): 10091016.
  • Buresi MC, Buret AG, Hollenberg MD, MacNaughton WK (2002). Activation of proteinase-activated receptor 1 stimulates epithelial chloride secretion through a unique MAP kinase- and cyclo-oxygenase-dependent pathway. FASEB J 16: 15151525.
  • Buresi MC, Vergnolle N, Sharkey KA, Keenan CM, Andrade-Gordon P, Cirino G et al. (2005). Activation of proteinase-activated receptor-1 inhibits neurally evoked chloride secretion in the mouse colon in vitro. Am J Physiol Gastrointest Liver Physiol 288: G337G345.
  • Caruso R, Pallone F, Fina D, Gioia V, Peluso I, Caprioli F et al. (2006). Protease-activated receptor-2 activation in gastric cancer cells promotes epidermal growth factor receptor trans-activation and proliferation. Am J Pathol 169: 268278.
  • Cattaruzza F, Cenac N, Barocelli E, Impicciatore M, Hyun E, Vergnolle N et al. (2006). Protective effect of proteinase-activated receptor 2 activation on motility impairment and tissue damage induced by intestinal ischemia/reperfusion in rodents. Am J Pathol 169: 177188.
  • Cenac N, Andrews CN, Holzhausen M, Chapman K, Cottrell G, Andrade-Gordon P et al. (2007). Role for protease activity in visceral pain in irritable bowel syndrome. J Clin Invest 117: 636647.
  • Cenac N, Cellars L, Steinhoff M, Andrade-Gordon P, Hollenberg MD, Wallace JL et al. (2005). Proteinase-activated receptor-1 is an anti-inflammatory signal for colitis mediated by a type 2 immune response. Inflamm Bowel Dis 11: 792798.
  • Cenac N, Chin AC, Garcia-Villar R, Salvador-Cartier C, Ferrier L, Vergnolle N et al. (2004). PAR2 activation alters colonic paracellular permeability in mice via IFN-gamma-dependent and -independent pathways. J Physiol 558: 913925.
  • Chen HM, Chen JC, Hwang TL, Jan YY, Chen MF (2000). Prospective and randomized study of gabexate mesilate for the treatment of severe acute pancreatitis with organ dysfunction. Hepatogastroenterology 47: 11471150.
  • Chiba N (1997). Proton pump inhibitors in acute healing and maintenance of erosive or worse esophagitis: a systematic overview. Can J Gastroenterol 11 (Suppl B): 66B73B.
  • Chin AC, Vergnolle N, MacNaughton WK, Wallace JL, Hollenberg MD, Buret AG (2003). Proteinase-activated receptor 1 activation induces epithelial apoptosis and increases intestinal permeability. Proc Natl Acad Sci USA 100: 1110411109.
  • Cocks TM, Fong B, Chow JM, Anderson GP, Frauman AG, Goldie RG et al. (1999a). A protective role for protease-activated receptors in the airways. Nature 398: 156160.
  • Cocks TM, Sozzi V, Moffatt JD, Selemidis S (1999b). Protease-activated receptors mediate apamin-sensitive relaxation of mouse and guinea pig gastrointestinal smooth muscle. Gastroenterology 116: 586592.
  • Coelho AM, Vergnolle N, Guiard B, Fioramonti J, Bueno L (2002). Proteinases and proteinase-activated receptor 2: a possible role to promote visceral hyperalgesia in rats. Gastroenterology 122: 10351047.
  • Corvera CU, Dery O, McConalogue K, Bohm SK, Khitin LM, Caughey GH et al. (1997). Mast cell tryptase regulates rat colonic myocytes through proteinase-activated receptor 2. J Clin Invest 100: 13831393.
  • Cottrell GS, Amadesi S, Pikios S, Camerer E, Willardsen JA, Murphy BR et al. (2007). Protease-activated receptor 2, dipeptidyl peptidase I, and proteases mediate clostridium difficile toxin A enteritis. Gastroenterology 132: 24222437.
  • Cuffe JE, Bertog M, Velazquez-Rocha S, Dery O, Bunnett N, Korbmacher C (2002). Basolateral PAR-2 receptors mediate KCl secretion and inhibition of Na+ absorption in the mouse distal colon. J Physiol 539: 209222.
  • Darmoul D, Gratio V, Devaud H, Laburthe M (2004a). Protease-activated receptor 2 in colon cancer: trypsin-induced MAPK phosphorylation and cell proliferation are mediated by epidermal growth factor receptor transactivation. J Biol Chem 279: 2092720934.
  • Darmoul D, Gratio V, Devaud H, Peiretti F, Laburthe M (2004b). Activation of proteinase-activated receptor 1 promotes human colon cancer cell proliferation through epidermal growth factor receptor transactivation. Mol Cancer Res 2: 514522.
  • Fiorucci S, Distrutti E, Federici B, Palazzetti B, Baldoni M, Morelli A et al. (2003). PAR-2 modulates pepsinogen secretion from gastric-isolated chief cells. Am J Physiol Gastrointest Liver Physiol 285: G611G620.
  • Fiorucci S, Mencarelli A, Palazzetti B, Distrutti E, Vergnolle N, Hollenberg MD et al. (2001). Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis. Proc Natl Acad Sci USA 98: 1393613941.
  • Fujimoto D, Hirono Y, Goi T, Katayama K, Hirose K, Yamaguchi A (2006). Expression of protease activated receptor-2 (PAR-2) in gastric cancer. J Surg Oncol 93: 139144.
  • Green BT, Bunnett NW, Kulkarni-Narla A, Steinhoff M, Brown DR (2000). Intestinal type 2 proteinase-activated receptors: expression in opioid-sensitive secretomotor neural circuits that mediate epithelial ion transport. J Pharmacol Exp Ther 295: 410416.
  • Griesbacher T, Lembeck F (1992). Effects of the bradykinin antagonist, HOE 140, in experimental acute pancreatitis. Br J Pharmacol 107: 356360.
  • Griesbacher T, Rainer I, Tiran B, Evans DM (2002). Involvement of tissue kallikrein but not plasma kallikrein in the development of symptoms mediated by endogenous kinins in acute pancreatitis in rats. Br J Pharmacol 137: 692700.
  • Hansen KK, Sherman PM, Cellars L, Andrade-Gordon P, Pan Z, Baruch A et al. (2005). A major role for proteolytic activity and proteinase-activated receptor-2 in the pathogenesis of infectious colitis. Proc Natl Acad Sci USA 102: 83638368.
  • Harada H, Miyake H, Ochi K, Tanaka J, Kimura I (1991). Clinical trial with a protease inhibitor gabexate mesilate in acute pancreatitis. Int J Pancreatol 9: 7579.
  • Hollenberg MD (2005). Physiology and pathophysiology of proteinase-activated receptors (PARs): proteinases as hormone-like signal messengers: PARs and more. J Pharmacol Sci 97: 813.
  • Hollenberg MD, Saifeddine M, Al-Ani B, Kawabata A (1997). Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides. Can J Physiol Pharmacol 75: 832841.
  • Hoogerwerf WA, Shenoy M, Winston JH, Xiao SY, He Z, Pasricha PJ (2004). Trypsin mediates nociception via the proteinase-activated receptor 2: a potentially novel role in pancreatic pain. Gastroenterology 127: 883891.
  • Hoogerwerf WA, Zou L, Shenoy M, Sun D, Micci MA, Lee-Hellmich H et al. (2001). The proteinase-activated receptor 2 is involved in nociception. J Neurosci 21: 90369042.
  • Hutter MM, Wick EC, Day AL, Maa J, Zerega EC, Richmond AC et al. (2005). Transient receptor potential vanilloid (TRPV-1) promotes neurogenic inflammation in the pancreas via activation of the neurokinin-1 receptor (NK-1R). Pancreas 30: 260265.
  • Ichikawa T, Ishihara K, Kusakabe T, Hiruma H, Kawakami T, Hotta K (2000). CGRP modulates mucin synthesis in surface mucus cells of rat gastric oxyntic mucosa. Am J Physiol Gastrointest Liver Physiol 279: G82G89.
  • Ishihara H, Connolly AJ, Zeng D, Kahn ML, Zheng YW, Timmons C et al. (1997). Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 386: 502506.
  • Ishikura H, Nishimura S, Matsunami M, Tsujiuchi T, Ishiki T, Sekiguchi F et al. (2007). The proteinase inhibitor camostat mesilate suppresses pancreatic pain in rodents. Life Sci 80: 19992004.
  • Isozaki Y, Yoshida N, Kuroda M, Handa O, Takagi T, Kokura S et al. (2006). Anti-tryptase treatment using nafamostat mesilate has a therapeutic effect on experimental colitis. Scand J Gastroenterol 41: 944953.
  • Iwaki M, Ino Y, Motoyoshi A, Ozeki M, Sato T, Kurumi M et al. (1986). Pharmacological studies of FUT-175, nafamostat mesilate. V. Effects on the pancreatic enzymes and experimental acute pancreatitis in rats. Jpn J Pharmacol 41: 155162.
  • Kahn ML, Zheng YW, Huang W, Bigornia V, Zeng D, Moff S et al. (1998). A dual thrombin receptor system for platelet activation. Nature 394: 690694.
  • Kawabata A (2002). PAR-2: structure, function and relevance to human diseases of the gastric mucosa. Expert Rev Mol Med 2002: 117.
  • Kawabata A (2003). Gastrointestinal functions of proteinase-activated receptors. Life Sci 74: 247254.
  • Kawabata A, Itoh H, Kawao N, Kuroda R, Sekiguchi F, Masuko T et al. (2004a). Activation of trigeminal nociceptive neurons by parotid PAR-2 activation in rats. NeuroReport 15: 16171621.
  • Kawabata A, Kanke T, Yonezawa D, Ishiki T, Saka M, Kabeya M et al. (2004b). Potent and metabolically stable agonists for protease-activated receptor-2: evaluation of activity in multiple assay systems in vitro and in vivo. J Pharmacol Exp Ther 309: 10981107.
  • Kawabata A, Kawao N, Kitano T, Matsunami M, Satoh R, Ishiki T et al. (2006a). Colonic hyperalgesia triggered by proteinase-activated receptor-2 in mice: involvement of endogenous bradykinin. Neurosci Lett 402: 167172.
  • Kawabata A, Kawao N, Kuroda R, Itoh H, Nishikawa H (2002a). Specific expression of spinal Fos after PAR-2 stimulation in mast cell-depleted rats. NeuroReport 13: 511514.
  • Kawabata A, Kawao N, Kuroda R, Tanaka A, Itoh H, Nishikawa H (2001a). Peripheral PAR-2 triggers thermal hyperalgesia and nociceptive responses in rats. NeuroReport 12: 715719.
  • Kawabata A, Kinoshita M, Nishikawa H, Kuroda R, Nishida M, Araki H et al. (2001b). The protease-activated receptor-2 agonist induces gastric mucus secretion and mucosal cytoprotection. J Clin Invest 107: 14431450.
  • Kawabata A, Kuroda R, Kuroki N, Nishikawa H, Kawai K (2000a). Dual modulation by thrombin of the motility of rat oesophageal muscularis mucosae via two distinct protease-activated receptors (PARs): a novel role for PAR-4 as opposed to PAR-1. Br J Pharmacol 131: 578584.
  • Kawabata A, Kuroda R, Kuroki N, Nishikawa H, Kawai K, Araki H (2000b). Characterization of the protease-activated receptor-1-mediated contraction and relaxation in the rat duodenal smooth muscle. Life Sci 67: 25212530.
  • Kawabata A, Kuroda R, Nagata N, Kawao N, Masuko T, Nishikawa H et al. (2001c). In vivo evidence that protease-activated receptors 1 and 2 modulate gastrointestinal transit in the mouse. Br J Pharmacol 133: 12131218.
  • Kawabata A, Kuroda R, Nishida M, Nagata N, Sakaguchi Y, Kawao N et al. (2002b). Protease-activated receptor-2 (PAR-2) in the pancreas and parotid gland: immunolocalization and involvement of nitric oxide in the evoked amylase secretion. Life Sci 71: 24352446.
  • Kawabata A, Kuroda R, Nishikawa H, Kawai K (1999a). Modulation by protease-activated receptors of the rat duodenal motility in vitro: possible mechanisms underlying the evoked contraction and relaxation. Br J Pharmacol 128: 865872.
  • Kawabata A, Matsunami M, Tsutsumi M, Ishiki T, Fukushima O, Sekiguchi F et al. (2006b). Suppression of pancreatitis-related allodynia/hyperalgesia by proteinase-activated receptor-2 in mice. Br J Pharmacol 148: 5460.
  • Kawabata A, Morimoto N, Nishikawa H, Kuroda R, Oda Y, Kakehi K (2000c). Activation of protease-activated receptor-2 (PAR-2) triggers mucin secretion in the rat sublingual gland. Biochem Biophys Res Commun 270: 298302.
  • Kawabata A, Nakaya Y, Ishiki T, Kubo S, Kuroda R, Sekiguchi F et al. (2004c). Receptor-activating peptides for PAR-1 and PAR-2 relax rat gastric artery via multiple mechanisms. Life Sci 75: 26892702.
  • Kawabata A, Nakaya Y, Kuroda R, Wakisaka M, Masuko T, Nishikawa H et al. (2003). Involvement of EDHF in the hypotension and increased gastric mucosal blood flow caused by PAR-2 activation in rats. Br J Pharmacol 140: 247254.
  • Kawabata A, Nishikawa H, Kuroda R, Kawai K, Hollenberg MD (2000d). Proteinase-activated receptor-2 (PAR-2): regulation of salivary and pancreatic exocrine secretion in vivo in rats and mice. Br J Pharmacol 129: 18081814.
  • Kawabata A, Nishikawa H, Saitoh H, Nakaya Y, Hiramatsu K, Kubo S et al. (2004d). A protective role of protease-activated receptor 1 in rat gastric mucosa. Gastroenterology 126: 208219.
  • Kawabata A, Oono Y, Yonezawa D, Hiramatsu K, Inoi N, Sekiguchi F et al. (2005). 2-Furoyl-LIGRL-NH2, a potent agonist for proteinase-activated receptor-2, as a gastric mucosal cytoprotective agent in mice. Br J Pharmacol 144: 212219.
  • Kawabata A, Saifeddine M, Al-Ani B, Leblond L, Hollenberg MD (1999b). Evaluation of proteinase-activated receptor-1 (PAR1) agonists and antagonists using a cultured cell receptor desensitization assay: activation of PAR2 by PAR1-targeted ligands. J Pharmacol Exp Ther 288: 358370.
  • Kawao N, Hiramatsu K, Inoi N, Kuroda R, Nishikawa H, Sekiguchi F et al. (2003). The PAR-1-activating peptide facilitates pepsinogen secretion in rats. Peptides 24: 14491451.
  • Kawao N, Ikeda H, Kitano T, Kuroda R, Sekiguchi F, Kataoka K et al. (2004). Modulation of capsaicin-evoked visceral pain and referred hyperalgesia by protease-activated receptors 1 and 2. J Pharmacol Sci 94: 277285.
  • Kawao N, Nagataki M, Nagasawa K, Kubo S, Cushing K, Wada T et al. (2005). Signal transduction for proteinase-activated receptor-2-triggered prostaglandin E2 formation in human lung epithelial cells. J Pharmacol Exp Ther 315: 576589.
  • Kawao N, Sakaguchi Y, Tagome A, Kuroda R, Nishida S, Irimajiri K et al. (2002a). Protease-activated receptor-2 (PAR-2) in the rat gastric mucosa: immunolocalization and facilitation of pepsin/pepsinogen secretion. Br J Pharmacol 135: 12921296.
  • Kawao N, Shimada C, Itoh H, Kuroda R, Kawabata A (2002b). Capsazepine inhibits thermal hyperalgesia but not nociception triggered by protease-activated receptor-2 in rats. Jpn J Pharmacol 89: 184187.
  • Kayssi A, Amadesi S, Bautista F, Bunnett NW, Vanner S (2007). Mechanisms of protease-activated receptor 2-evoked hyperexcitability of nociceptive neurons innervating the mouse colon. J Physiol 580: 977991.
  • Kim JA, Choi SC, Yun KJ, Kim DK, Han MK, Seo GS et al. (2003). Expression of protease-activated receptor 2 in ulcerative colitis. Inflamm Bowel Dis 9: 224229.
  • Kirkland JG, Cottrell GS, Bunnett NW, Corvera CU (2007). Agonists of protease-activated receptors 1 and 2 stimulate electrolyte secretion from mouse gallbladder. Am J Physiol Gastrointest Liver Physiol 293: G335G346.
  • Kong W, McConalogue K, Khitin LM, Hollenberg MD, Payan DG, Bohm SK et al. (1997). Luminal trypsin may regulate enterocytes through proteinase-activated receptor 2. Proc Natl Acad Sci USA 94: 88848889.
  • Kubo S, Ishiki T, Doe I, Sekiguchi F, Nishikawa H, Kawai K et al. (2006). Distinct activity of peptide mimetic intracellular ligands (pepducins) for proteinase-activated receptor-1 in multiple cells/tissues. Ann N Y Acad Sci 1091: 445459.
  • Maeda K, Hirota M, Kimura Y, Ichihara A, Ohmuraya M, Sugita H et al. (2005). Proinflammatory role of trypsin and protease-activated receptor-2 in a rat model of acute pancreatitis. Pancreas 31: 5462.
  • Mall M, Gonska T, Thomas J, Hirtz S, Schreiber R, Kunzelmann K (2002). Activation of ion secretion via proteinase-activated receptor-2 in human colon. Am J Physiol Gastrointest Liver Physiol 282: G200G210.
  • Matej R, Housa D, Olejar T (2006). Acute pancreatitis: proteinase-activated receptor-2 as Dr. Jekyll and Mr. Hyde. Physiol Res 55: 467474.
  • McLaughlin JN, Patterson MM, Malik AB (2007). Protease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization. Proc Natl Acad Sci USA 104: 56625667.
  • Molino M, Barnathan ES, Numerof R, Clark J, Dreyer M, Cumashi A et al. (1997). Interactions of mast cell tryptase with thrombin receptors and PAR-2. J Biol Chem 272: 40434049.
  • Mule F, Baffi MC, Capparelli A, Pizzuti R (2003). Involvement of nitric oxide and tachykinins in the effects induced by protease-activated receptors in rat colon longitudinal muscle. Br J Pharmacol 139: 598604.
  • Mule F, Baffi MC, Cerra MC (2002a). Dual effect mediated by protease-activated receptors on the mechanical activity of rat colon. Br J Pharmacol 136: 367374.
  • Mule F, Baffi MC, Falzone M, Cerra MC (2002b). Signal transduction pathways involved in the mechanical responses to protease-activated receptors in rat colon. J Pharmacol Exp Ther 303: 12651272.
  • Mule F, Pizzuti R, Capparelli A, Vergnolle N (2004). Evidence for the presence of functional protease activated receptor 4 (PAR4) in the rat colon. Gut 53: 229234.
  • Naito Y, Uchiyama K, Kuroda M, Takagi T, Kokura S, Yoshida N et al. (2006). Role of pancreatic trypsin in chronic esophagitis induced by gastroduodenal reflux in rats. J Gastroenterol 41: 198208.
  • Nakanishi-Matsui M, Zheng YW, Sulciner DJ, Weiss EJ, Ludeman MJ, Coughlin SR (2000). PAR3 is a cofactor for PAR4 activation by thrombin. Nature 404: 609613.
  • Namkung W, Han W, Luo X, Muallem S, Cho KH, Kim KH et al. (2004). Protease-activated receptor 2 exerts local protection and mediates some systemic complications in acute pancreatitis. Gastroenterology 126: 18441859.
  • Nathan JD, Patel AA, McVey DC, Thomas JE, Prpic V, Vigna SR et al. (2001). Capsaicin vanilloid receptor-1 mediates substance P release in experimental pancreatitis. Am J Physiol Gastrointest Liver Physiol 281: G1322G1328.
  • Nathan JD, Peng RY, Wang Y, McVey DC, Vigna SR, Liddle RA (2002). Primary sensory neurons: a common final pathway for inflammation in experimental pancreatitis in rats. Am J Physiol Gastrointest Liver Physiol 283: G938G946.
  • Nguyen QD, De Wever O, Bruyneel E, Hendrix A, Xie WZ, Lombet A et al. (2005). Commutators of PAR-1 signaling in cancer cell invasion reveal an essential role of the Rho–Rho kinase axis and tumor microenvironment. Oncogene 24: 82408251.
  • Nguyen TD, Moody MW, Steinhoff M, Okolo C, Koh DS, Bunnett NW (1999). Trypsin activates pancreatic duct epithelial cell ion channels through proteinase-activated receptor-2. J Clin Invest 103: 261269.
  • Nishikawa H, Kawai K, Nishimura S, Tanaka S, Araki H, Al-Ani B et al. (2002). Suppression by protease-activated receptor-2 activation of gastric acid secretion in rats. Eur J Pharmacol 447: 8790.
  • Nishikawa H, Kawai K, Tanaka M, Ohtani H, Tanaka S, Kitagawa C et al. (2005). Protease-activated receptor-2 (PAR-2)-related peptides induce tear secretion in rats: involvement of PAR-2 and non-PAR-2 mechanisms. J Pharmacol Exp Ther 312: 324331.
  • Nishiyama T, Nakamura T, Obara K, Inoue H, Mishima K, Matsumoto N et al. (2007). Up-regulated PAR-2-mediated salivary secretion in mice deficient in muscarinic acetylcholine receptor subtypes. J Pharmacol Exp Ther 320: 516524.
  • Nystedt S, Emilsson K, Wahlestedt C, Sundelin J (1994). Molecular cloning of a potential proteinase activated receptor. Proc Natl Acad Sci USA 91: 92089212.
  • Oikonomopoulou K, Hansen KK, Saifeddine M, Tea I, Blaber M, Blaber SI et al. (2006a). Proteinase-activated receptors, targets for kallikrein signaling. J Biol Chem 281: 3209532112.
  • Oikonomopoulou K, Hansen KK, Saifeddine M, Vergnolle N, Tea I, Diamandis EP et al. (2006b). Proteinase-mediated cell signalling: targeting proteinase-activated receptors (PARs) by kallikreins and more. Biol Chem 387: 677685.
  • Olejar T, Matej R, Zadinova M, Pouckova P (2001). Expression of proteinase-activated receptor 2 during taurocholate-induced acute pancreatic lesion development in Wistar rats. Int J Gastrointest Cancer 30: 113121.
  • Ossovskaya VS, Bunnett NW (2004). Protease-activated receptors: contribution to physiology and disease. Physiol Rev 84: 579621.
  • Otsuki M, Tani S, Okabayashi Y, Fuji M, Nakamura T, Fujisawa T et al. (1990). Beneficial effects of the synthetic trypsin inhibitor camostate in cerulein-induced acute pancreatitis in rats. Dig Dis Sci 35: 242250.
  • Roka R, Demaude J, Cenac N, Ferrier L, Salvador-Cartier C, Garcia-Villar R et al. (2007). Colonic luminal proteases activate colonocyte proteinase-activated receptor-2 and regulate paracellular permeability in mice. Neurogastroenterol Motil 19: 5765.
  • Saifeddine M, Al-Ani B, Cheng CH, Wang L, Hollenberg MD (1996). Rat proteinase-activated receptor-2 (PAR-2): cDNA sequence and activity of receptor-derived peptides in gastric and vascular tissue. Br J Pharmacol 118: 521530.
  • Sato K, Ninomiya H, Ohkura S, Ozaki H, Nasu T (2006). Impairment of PAR-2-mediated relaxation system in colonic smooth muscle after intestinal inflammation. Br J Pharmacol 148: 200207.
  • Sekiguchi F, Hasegawa N, Inoshita K, Yonezawa D, Inoi N, Kanke T et al. (2006). Mechanisms for modulation of mouse gastrointestinal motility by proteinase-activated receptor (PAR)-1 and -2 in vitro. Life Sci 78: 950957.
  • Sekiguchi F, Saito S, Takaoka K, Hayashi H, Nagataki M, Nagasawa K et al. (2007). Mechanisms for prostaglandin E2 formation caused by proteinase-activated receptor-1 activation in rat gastric mucosal epithelial cells. Biochem Pharmacol 73: 103114.
  • Seo JH, Kim KH, Kim H (2007). Role of proteinase-activated receptor-2 on cyclooxygenase-2 expression in H. pylori-infected gastric epithelial cells. Ann N Y Acad Sci 1096: 2936.
  • Sharma A, Tao X, Gopal A, Ligon B, Andrade-Gordon P, Steer ML et al. (2005a). Protection against acute pancreatitis by activation of protease-activated receptor-2. Am J Physiol Gastrointest Liver Physiol 288: G388G395.
  • Sharma A, Tao X, Gopal A, Ligon B, Steer ML, Perides G (2005b). Calcium dependence of proteinase-activated receptor 2 and cholecystokinin-mediated amylase secretion from pancreatic acini. Am J Physiol Gastrointest Liver Physiol 289: G686G695.
  • Singh VP, Bhagat L, Navina S, Sharif R, Dawra R, Saluja AK (2007). PAR-2 protects against pancreatitis by stimulating exocrine secretion. Gut 56: 958964.
  • Steinhoff M, Vergnolle N, Young SH, Tognetto M, Amadesi S, Ennes HS et al. (2000). Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med 6: 151158.
  • Sun G, Stacey MA, Schmidt M, Mori L, Mattoli S (2001). Interaction of mite allergens Der p3 and Der p9 with protease-activated receptor-2 expressed by lung epithelial cells. J Immunol 167: 10141021.
  • Takeda K, Matsuno S, Sunamura M, Kakugawa Y (1996). Continuous regional arterial infusion of protease inhibitor and antibiotics in acute necrotizing pancreatitis. Am J Surg 171: 394398.
  • Toyoda N, Gabazza EC, Inoue H, Araki K, Nakashima S, Oka S et al. (2003). Expression and cytoprotective effect of protease-activated receptor-1 in gastric epithelial cells. Scand J Gastroenterol 38: 253259.
  • Tsuboi H, Naito Y, Katada K, Takagi T, Handa O, Kokura S et al. (2007). Role of the thrombin/protease-activated receptor 1 pathway in intestinal ischemia–reperfusion injury in rats. Am J Physiol Gastrointest Liver Physiol 292: G678G683.
  • Vergnolle N, Bunnett NW, Sharkey KA, Brussee V, Compton SJ, Grady EF et al. (2001). Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway. Nat Med 7: 821826.
  • Vergnolle N, Macnaughton WK, Al-Ani B, Saifeddine M, Wallace JL, Hollenberg MD (1998). Proteinase-activated receptor 2 (PAR2)-activating peptides: identification of a receptor distinct from PAR2 that regulates intestinal transport. Proc Natl Acad Sci USA 95: 77667771.
  • Vu TK, Hung DT, Wheaton VI, Coughlin SR (1991a). Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64: 10571068.
  • Vu TK, Wheaton VI, Hung DT, Charo I, Coughlin SR (1991b). Domains specifying thrombin-receptor interaction. Nature 353: 674677.
  • Xu WF, Andersen H, Whitmore TE, Presnell SR, Yee DP, Ching A et al. (1998). Cloning and characterization of human protease-activated receptor 4. Proc Natl Acad Sci USA 95: 66426646.
  • Yoshida N, Isozaki Y, Takagi T, Takenaka S, Uchikawa R, Arizono N et al. (2006a). Review article: anti-tryptase therapy in inflammatory bowel disease. Aliment Pharmacol Ther 24 (Suppl 4): 249255.
  • Yoshida N, Kajikawa H, Katada K, Kirayama F, Handa O, Takagi T et al. (2006b). H. pylori protease activates gastric epithelial cells to produce IL-8 through protease-activated receptor 2. Gastroenterology 130 (Suppl 2): A522.
  • Yoshida N, Katada K, Handa O, Takagi T, Kokura S, Naito Y et al. (2007). Interleukin-8 production via protease-activated receptor 2 in human esophageal epithelial cells. Int J Mol Med 19: 335340.
  • Zhao A, Shea-Donohue T (2003). PAR-2 agonists induce contraction of murine small intestine through neurokinin receptors. Am J Physiol Gastrointest Liver Physiol 285: G696G703.
  • Zheng XL, Renaux B, Hollenberg MD (1998). Parallel contractile signal transduction pathways activated by receptors for thrombin and epidermal growth factor-urogastrone in guinea pig gastric smooth muscle: blockade by inhibitors of mitogen-activated protein kinase-kinase and phosphatidyl inositol 3′-kinase. J Pharmacol Exp Ther 285: 325334.